RECOVERY & TISSUE REPAIR / FAQ

Questions From the Research Record

Direct, citation-anchored answers to the questions readers most often bring to TB-500 and the blends built from it.

What is GLOW peptide?

GLOW isn't a single peptide — it's a research-vial blend of three peptides: GHK-Cu (a copper-carrying tripeptide), BPC-157 (a gut-derived pentadecapeptide) and TB-500 (a thymosin beta-4 fragment). It's most often marketed for skin renewal alongside general tissue repair. No controlled study has tested the three-peptide combination itself; every claim about GLOW is built from research on its separate ingredients [1][2][4].

What does the GLOW peptide do?

Its three ingredients are thought to work on different parts of the repair process at once: GHK-Cu nudges skin cells to build more collagen and matrix, BPC-157 helps switch on new blood-vessel growth toward damaged tissue, and TB-500's fragment is believed to help cells migrate to an injury site. Community reports describe brighter, smoother-looking skin and faster-feeling recovery from minor injuries, but these are anecdotal, not clinical evidence — there is no blend-level study confirming any of it [3][4].

What does GLOW peptide have in it?

The typical research-label composition is GHK-Cu, BPC-157 and TB-500, most commonly listed around a 50 mg / 10 mg / 10 mg ratio in one vial. Ratios vary by supplier and are not independently standardized or verified.

What peptides are in the GLOW blend?

Three: GHK-Cu (a copper tripeptide), BPC-157 (a pentadecapeptide derived from a stomach-protective protein) and TB-500 (the Ac-LKKTETQ thymosin beta-4 fragment). Some clinics and suppliers use slightly different ratios, but these three ingredients define the blend.

What is KLOW peptide?

KLOW is a four-peptide research blend: KPV, GHK-Cu, BPC-157 and TB-500 — essentially GLOW's three ingredients with a fourth, anti-inflammatory peptide (KPV) added. A commonly listed vial recipe is 50 mg GHK-Cu with 10 mg each of BPC-157, TB-500 and KPV. It is not FDA-approved and has no combination-level safety or efficacy data [1].

What is KLOW peptide used for?

In research communities, KLOW is discussed mainly for recovery from tendon, ligament and joint injuries, general achiness, and — via its shared ingredients with GLOW — some skin and gut-comfort effects. These are anecdotal community reports, not clinical indications; no regulatory body has approved KLOW for any human use.

Where do you inject KLOW peptide?

This site does not provide injection instructions, sites, or dosing guidance for any compound, including KLOW. KLOW is supplied strictly as a research chemical, not an approved medicine, and nothing here should be read as a recommendation for human administration. Community write-ups describe subcutaneous use, but this site does not endorse or detail that practice.

How much KLOW peptide per day?

This site does not recommend a dose, schedule or frequency for KLOW or any compound discussed here. No controlled human study has established a dose for the four-peptide combination — figures circulated in research communities are unverified and not derived from clinical trials.

What is TB-500?

TB-500 is the common name for a synthetic seven-amino-acid fragment (Ac-LKKTETQ) of a larger natural protein, thymosin beta-4, corresponding to the protein's actin-binding region. Most published efficacy research used the full-length protein rather than this smaller fragment, a distinction the research literature is explicit about [12].

What does TB-500 stand for and what does TB stand for in TB-500?

'TB' refers to thymosin beta — TB-500 is a synthetic fragment derived from thymosin beta-4, a naturally occurring repair protein. The '500' in the name is a supplier-derived catalog designation rather than a chemical or dosing reference; it doesn't correspond to a molecular weight or a standard dose.

What is TB-500 used for in research?

TB-500, and in the underlying research its parent protein thymosin beta-4, is studied for cell migration, new blood-vessel growth, and wound and tendon repair. A 2026 review of unapproved peptide therapies for musculoskeletal conditions names it among compounds with favorable animal-model outcomes but scarce human safety data [1]. It has no FDA-approved therapeutic use and is sold for laboratory research only.

Does TB-500 work for muscle tears and recovery from exercise?

Research communities frequently report faster-feeling recovery from tendon, ligament and muscle injuries with TB-500 — this is the single most common reason people describe using it, but it is anecdotal, not a measured clinical outcome. Controlled evidence is thinner and mostly indirect: animal studies of the full-length parent protein show improved tissue repair and reduced scarring in models like stroke and skin wounds [11][12], but no controlled human trial has tested TB-500 specifically for muscle-tear recovery or exercise recovery.